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Abstract
Background and aims While mature enterocytes are resistant to
transduction by adenovirus type 5 (Ad5) vectors, undifferentiated cells are
transduced much more efficiently. Our purpose was to study enterocyte
transduction in models of intestinal wound healing.
Methods Transduction was studied ex vivo using cultures of endoscopic
biopsies and in vitro utilizing Caco-2 cells in models of mucosal wound
healing. Vectors carried either the LacZ or the luciferase gene. CAR
(coxsackievirus and adenovirus receptor) and integrins were studied with
transduction inhibition and immunofluorescent staining.
Results Increased transduction efficiency was observed for a subset of
enterocytes with a flattened de-differentiated phenotype present at the
edge of cultured biopsies. In the in vitro systems, expanding Caco-2 cell
monolayers exhibited increased transducibility that was time- and dose-
dependent, reaching virtually 100% in cells along the leading edge at high
viral load. Bioluminescence activity of transduced expanding monolayers was
up to 3-fold greater than that of non-expanding monolayers (‘fence’ system,
48 h, MOI 1000, p < 0.05). Mitomycin C pre-treatment did not affect levels of
transduction in expanding monolayers. At the highest viral load tested, CAR
or integrin blocking prior to virus application resulted in 39.4% and 45.4%
reduction in transduction levels (p < 0.05). Immunofluorescence revealed
altered expression of CAR on the migrating edge of the Caco-2 cultures and
the expression of CAR on the apical membrane of biopsy enterocytes.
Conclusions Increased CAR and integrin accessibility in migrating
enterocytes mediates increased transduction by Ad5 vectors. This subset
of enterocytes provides a target for the delivery of genes of interest for both
research and gene therapy applications. Copyright  2006 John Wiley &
Sons, Ltd.
Keywords Caco-2 cells; wound healing; coxsackievirus and adenovirus receptor;
adenovirus; enterocytes; inflammatory bowel disease
Introduction
Adenoviruses are valuable gene delivery vectors for manipulation of cel-
lular genes/processes, for both research applications and gene therapy
strategies. Adenoviruses are naturally responsible for human respiratory
and gastrointestinal infections [1], suggesting that epithelial cells may
be possible targets for recombinant adenoviral vectors. The intestinal
epithelium itself presents several advantages as a gene delivery target,
Copyright  2006 John Wiley & Sons, Ltd.
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such as ease of access via the lumenal route, large tissue
mass, increased numbers of rapidly proliferating cells,
and access to epithelial stem cells located in the crypts of
Lieberkuhn [2,3]. Local expression of the transgene could
prove particularly advantageous for studying or treating
gastrointestinal diseases originating in the intestinal wall
such as inflammatory bowel disease and colon cancer.
One of the major obstacles to utilizing recombinant
adenoviruses for gastrointestinal gene delivery is the
relatively low transduction efficiency of mature intestinal
epithelial cells by adenoviral vectors as seen both in vitro
[4–6] and in vivo [2–4,7]. In vitro studies showed that
transduction efficiency of enterocytes was concentration-
dependent and inversely correlated with degree of
differentiation and cell density [2,4–6]. In the case of
Caco-2 cells, a human colorectal adenocarcinoma cell line
that undergoes spontaneous enterocytic differentiation
in culture [8] and is extensively used as a model
of small intestinal epithelium, transduction efficiency
dramatically decreased after 3 days in culture when cells
began to differentiate [5,6]. Well-differentiated Caco-
2 cells that had been more than 2 weeks in culture
exhibited extremely low transducibility [5,6]. IEC-18
cells, which represent a less differentiated crypt cell-
like phenotype, were transduced more readily [4]. The
difference in transduction efficiency at the different
stages of differentiation has been partly attributed
to the fact that αν -integrins, known to facilitate the
adenovirus internalization process, are more accessible
to the virus on the apical membrane in the early
stages of differentiation [4,5]. In vivo studies further
confirmed that integrin expression significantly affected
gene transfer to the intestinal epithelium [4,9]. As a result,
adenoviral gene delivery to the intestine seems more
promising if targeted towards less well-differentiated
cells or in cases where epithelial integrity has been
impaired.
Restituting intestinal epithelial cells have been shown
to exhibit a less well-differentiated phenotype [10] and
therefore could be more susceptible to transduction by
adenoviral vectors. Utilizing an ex vivo culture system of
intestinal biopsies obtained at the time of endoscopy, we
observed increased transduction efficiency for a subset
of enterocytes with a flattened de-differentiated pheno-
type, present at the edges of the biopsy. This is the
first demonstration of increased transduction of restitut-
ing epithelial cells in human tissue. To mimic in vitro
the intestinal damage and mucosal wound healing con-
ditions, we used two well-established in vitro models of
restituting epithelium and studied differences in ade-
noviral transduction efficiency between migrating and
non-migrating cells. We further carried out transduc-
tion inhibition and immunofluorescence experiments to
study the role of integrins and CAR (coxsackievirus
and adenovirus receptor) in mediating increased trans-
duction in the migrating Caco-2 cells. Differences in
CAR expression were observed between migrating and
confluent Caco-2 cells. Apically accessible CAR appears
to be mediating the transduction of migrating Caco-2
cells. This is in contrast to other epithelial cell models
such as airway epithelium where basolaterally local-




Tissue culture reagents were obtained from Invitrogen
Co. (Carlsbad, CA, USA) and tissue culture materials
were from Becton Dickinson (Franklin Lakes, NJ, USA)
and Corning Inc. Life Sciences (Acton, MA, USA). The
GRGDSP RGD peptide was purchased from Bachem AG
(King of Prussia, PA, USA). All other chemicals used were
of analytical grade and purchased from Sigma (St. Louis,
MO, USA) and Fisher Scientific (Pittsburgh, PA, USA).
Human subjects
These studies were approved by the Institutional Review
Board of the University of Michigan Medical Center
(IRBMED #1998-0016). All subjects gave informed
consent. Endoscopic biopsies from the second portion of
the duodenum were obtained from patients undergoing
esophagogastroduodenoscopy for clinical indications
but whose duodeni appeared endoscopically normal.
Exclusion criteria were: age less than 18 years or greater
than 65 years, known HIV or viral hepatitis, coagulopathy,
use of anticoagulants such as aspirin or coumadin, or
inability to give informed consent. Two to six biopsies
were obtained from each of seven subjects.
Adenoviral vectors
Adenoviral type 5 (Ad5) vectors (Vector Core Laboratory,
University of Michigan) were used for all experiments.
Ad5CMV-luc and Ad5CMV-luc(loxP) vectors contained
the luciferase reporter gene in the E1A/E1B region of the
viral genome under the control of the cytomegalovirus
(CMV) promoter [12]. Ad5CMV-betaGal contained the
nuclear targeted beta-galactosidase (LacZ) gene. For the
modified Ad5SHORT vectors the endogenous Ad5 fiber
gene was replaced by the Ad41 short fiber gene. The
Ad5SHORT-luc vector is analogous to Ad5CMV-luc(loxP).
Ad5SHORT vectors were produced by homologous
recombination in E. coli BJ5183 recBC sbcBC [13,14].
Explant culture and transduction
Biopsies from endoscopically normal duodenum were
placed in organ culture as previously described [15] with
minor modifications. Explant culture medium consisted
of 8 parts CMRL medium 1066 (Gibco BRL, Grand Island,
NY, USA) combined with 2 parts F-12 (Ham) nutrient
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mixture (Gibco BRL), and then supplemented to the
indicated final concentrations with the following: fetal
bovine serum (FBS, 10%; Hyclone, Logan, UT, USA);
glucose (10 mM; Abbott Laboratories, N. Chicago, IL,
USA); GlutaMax I (2 mM; Gibco BRL); sodium selenite
(0.1 µM; Sigma); zinc sulfate (3 µM; Sigma); menadione
sodium bisulfite (145 nM; Sigma); vitamin E acetate
(45 nM; Sigma or Gibco); sodium penicillin G (100
U/ml; Gibco BRL); and gentamicin (50 µg/ml; Sigma).
All components used to supplement the medium were of
cell culture quality. Sterile normal saline was placed in the
outer well of each organ culture dish to ensure adequate
humidity.
Biopsies were transferred from the endoscopic biopsy
forceps into sterile transport medium [80% CMRL
medium 1066, 20% F-12 (Ham) nutrient mixture] that
had been pre-equilibrated with 5% CO2 in oxygen and
kept on ice. After immediate transport to the laboratory,
each biopsy was oriented lumenal-side up (with the aid of
a dissecting microscope) on a stainless steel screen in an
organ culture dish (Falcon, Oxnard, CA, USA) containing
2.15 ml of explant culture medium pre-equilibrated with
5% CO2 in oxygen. The explants were only partially
submerged in this volume of medium. In the biological
safety cabinet, 4 µl of a suspension containing 4 × 1011
particles Ad5CMV-betaGal/ml were applied directly to
the upper surface of each explant (1.6 × 109 particles
per explant). At least two biopsies per patient were
used for transduction experiments which were performed
on separate occasions on biopsies from seven patients.
In preliminary experiments, cultured biopsies (explants)
were evaluated for structural integrity and were found
to maintain near normal morphology for up to 45 h with
identifiable microvilli and tight junctions. Exposure to
vectors during the culture period did not affect tissue
morphology [16].
The dishes were then placed on the rack of a modular
incubator chamber (Billups Rothenberg Incorporated,
Del Mar, CA, USA); open dishes containing water were
placed below the rack for humidification. The chamber
was gassed with approximately 10 volumes of 5% CO2
in oxygen over 15 min, then sealed and placed on a
rotating table in a 37 ◦C incubator. The rotating table
was turned on (at 40 rpm) 2 h after the application of
the vector. The start of gassing occurred approximately
45–60 min from the start of biopsy procurement and
was considered 0 h. Explants were kept in culture for
24–28 h at which point transduction was assayed by
X-Gal staining.
Cell culture
Caco-2 cells (ATCC HTB37) of passage 33–44 were main-
tained in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 20% heat-inactivated FBS, 0.1 mM
non-essential amino acids (NEAA), 45 nM vitamin E,
100 units/ml penicillin, and 100 µg/ml streptomycin
until confluent (typically 3 days). Medium was changed
to DMEM with 5% FBS, 0.1 mM NEAA, 45 nM vita-
min E, 0.1 µM selenium (Na2SeO3), 0.003 nM zinc
(ZnSO4 · 7H2O), 100 units/ml penicillin, and 100 µg/ml
streptomycin until the end of the experiment (typ-
ically 2 weeks). Cells were grown at 37 ◦C in an
atmosphere of 5% CO2 and 90% relative humid-
ity.
Adenoviral infection studies in the
wounded monolayer system
Caco-2 cells were seeded at a density of 4 × 105 cells/well
on porous collagen-coated polycarbonate cell culture
inserts with a pore size of 1 µm and a surface area of
0.9 cm2 (Corning Inc. Life Sciences) in 12-well plates.
Medium was changed every other day for 2 weeks in
both apical and basolateral chambers. Differentiated
monolayers were mechanically wounded by cutting the
monolayer with a cell scraper along one diameter of the
insert. Cells were washed with DMEM to remove cell
debris and feeding medium was added to both apical and
basolateral chambers. Cells were kept in culture for up
to 48 h to allow for wound healing to occur. Basolateral
medium was renewed while apical medium was replaced
with medium containing the desired adenoviral vector(s)
at a MOI (multiplicity of infection) of 10, 100, and 1000.
After a 2 h incubation at 37 ◦C, an equal amount of
medium was added to the apical chamber and cultures
were incubated for 24 or 48 h at 37 ◦C. At this time,
beta-galactosidase expression was assayed with X-Gal
staining while luciferase expression was assayed by
bioluminescence imaging.
Adenoviral infection studies in the
‘fence’ system
Caco-2 cells were seeded at a density of 3.33 × 105
cells/well in the central opening of stainless steel rings
(‘fences’) placed with the help of an O-ring in the
center of the wells of 6-well culture plates or 35 mm
culture dishes (‘fences’ kindly provided by Dr. Jerrold
R. Turner, University of Chicago). Cell growth area
was 0.79 cm2 and the volume of cell suspension used
was 500 µl. Medium was changed every other day until
cells reached a differentiated state. At this point, the
‘fence’ was removed and new medium was added. Radial
monolayer expansion occurs when the ‘fence’ is lifted
from the culture plate [17]. Monolayer expansion was
allowed to take place for 24 h after which medium was
replaced with adenovirus-containing medium (Ad5CMV
or Ad5SHORT; 10, 100 and 1000 MOI). Subsequent steps
were similar to the wounded monolayer system. In some
studies (conducted at the intermediate MOI of 200),
proliferation was first blocked by pre-treatment of the
monolayers with 20 µg/ml mitomycin C (Sigma) for 2 h
prior to fence removal. This mitomycin C concentration
has been shown to be sufficient to arrest cell proliferation
in Caco-2 cell cultures [18,19].
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Adenoviral infection studies in
differentiated Caco-2 cells
Caco-2 cells were seeded at a density of 4 × 105 cells/well
on porous collagen-coated polycarbonate cell culture
inserts with a pore size of 1 µm and a surface area
of 0.9 cm2 in 12-well plates. Medium was changed
every other day for 2 weeks in both apical and
basolateral chambers. Differentiated Caco-2 monolayers
were infected with the Ad5CMV-luc(loxP) vector at
the desired MOI, either apically or basolaterally.
Basolateral transduction was carried out by inverting the
culture inserts. Adenovirus transduction was allowed to
proceed for 2 h at 37 ◦C at which point medium was
aspirated, replenished with fresh medium, and cells were
returned to the incubator. Luminescence activity was
assayed after 48 h. In a separate set of experiments,
differentiated Caco-2 monolayers were treated with
2.5 mM ethylene glycol tetraacetic acid (EGTA) added
to both apical and basolateral chambers for 45 min at
37 ◦C. This concentration of EGTA has been previously
reported to be sufficient to widen the tight junctions
in Caco-2 cells [20,21]. Tight junction widening was
confirmed in our studies by a decrease in transepithelial
electrical resistance measurements before and after EGTA
treatment. Adenoviral infection was subsequently carried
out as described above.
X-Gal staining
At the end of the culture period, explants were fixed
in 2% formalin in phosphate-buffered saline (PBS)
for 2 h, washed twice for 5 min in PBS containing
2 mM magnesium chloride, and placed in X-Gal staining
solution [1 mg/ml X-Gal (5-bromo-4-chloro-3-indolyl-
β-D-galactoside), 5 mM potassium ferricyanide, 5 mM
potassium ferrocyanide, 2 mM magnesium chloride,
0.01% sodium deoxycholate, 0.02% Nonidet P-40] at
33 ◦C for 16–18 h. The tissue was then washed twice in
PBS and post-fixed in 10% neutral buffered formalin.
After 2 h in 10% formalin, the tissue was placed in
30% sucrose/10% formalin for an additional 24 h, then
embedded in O.C.T. compound (Miles Inc., Elkhart,
IN, USA) and frozen at −80 ◦C. All steps prior to
embedding were carried out on a rotating table at
40–60 rpm.
Sectioning and counterstaining
Sections of the O.C.T.-embedded tissue were prepared
with a cryostat and stored at −80 ◦C. Rehydrated sections
of the X-Gal-stained tissue were counterstained with
0.1% Nuclear Fast Red (Sigma; C.I. 60 760) in 5%
aluminum sulfate, then dehydrated through a graded
series of ethanol, cleared in xylene, and coverslipped with
Permount (Fisher Scientific).
Quantitation of X-Gal-stained nuclei
Without magnification, five sections without evidence of
folds were chosen from near the center of each explant
as judged by largest section size. Consecutive sections
were avoided. The morphology of the enterocytes in
each section was evaluated microscopically; the presence
or absence of columnar enterocytes and attenuated
enterocytes (at tissue edges or extending beneath the
tissue as a monolayer) was recorded. Note was made of
the presence or absence of transduced cells within these
subpopulations of enterocytes.
Bioluminescence imaging
At the end of the desired virus incubation time, medium
was replaced with feeding medium containing 0.15 or
0.4 mg/ml luciferin and incubated for 30 min at 37 ◦C.
Luciferase expression was quantified as bioluminescence
photon counts using a cryogenically cooled Xenogen
IVIS Imaging system (Xenogen Corporation, Alameda,
CA, USA) coupled to a data acquisition computer
at the Center for Molecular Imaging, University of
Michigan. A digital grayscale image was acquired followed
by acquisition and overlay of a pseudocolor image
representing the spatial distribution of detected photon
counts emerging from active luciferase within the wells.
Signal intensity was quantified as the sum of all detected
photons within the region of interest during a 1 or
3 min luminescent integration time, at level B. Results
were expressed as fold photon counts compared to
untransduced cells present in the plate.
Adenoviral infection inhibition studies
A mouse monoclonal antibody against human CAR was
produced by the Hybridoma Core, University of Michigan,
from a commercially available clone (ATCC #CRL-
2379) [22]. Infection inhibition studies were carried out
using the ‘fence’ system. Twenty-four hours after ‘fence’
removal, medium was replaced with blocking medium
containing either the monoclonal anti-CAR antibody
(ascites fluid 1 : 50, tissue culture supernatant 1 : 1)
or an RGD peptide (GRGDSP; 0.4 mM or 1 mM) that
blocks integrin binding [4]. Monolayers were incubated
with blocking medium for 2 h at room temperature
under gentle rotation. Blocking medium was replaced
by medium containing the desired MOI of adenoviral
vector(s) and plates were moved to the 37 ◦C incubator
to allow for virus infection to occur. After 2 h, vector-
containing medium was replaced with fresh medium
and culture was continued for 48 h before assessing
transduction efficiency. The studies were carried out at
the submaximal MOI of 200 and at the high MOI of
1000. The two RGD peptide concentrations of 0.4 mM and
1 mM were chosen based on results published on integrin-
binding inhibition in differentiated and undifferentiated
Caco-2 cells [4].
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Immunofluorescent detection of CAR
and cytokeratin
Intestinal explants were stained for cytokeratin and CAR.
For cytokeratin staining, archived sections of explants
(48 h culture), which had been fixed in 10% neutral
buffered formalin for >24 h and embedded in paraffin,
were deparaffinized and rehydrated through a graded
series of ethanol, then subjected to digestion with pepsin
(Zymed, South San Francisco, CA, USA) for 10 min
at 37 ◦C. After washing in PBS, non-specific binding
sites were blocked using 2% chicken serum, 1% bovine
serum albumin (BSA), 0.1% cold fish skin gelatin, and
0.05% Tween 20 in PBS containing 0.05% sodium
azide. The blocking solution was decanted from the
sections; then mouse anti-cytokeratin 8 & 18 (Zymed) or
MOPC 21 isotype control (both at 5 µg/ml) was applied
and incubated for 1 h at room temperature. For CAR
staining, sections of explants which had been fixed in
4% paraformaldehyde in PBS for 1 h and embedded
in paraffin after infiltration for 2 h at 60 ◦C were
deparaffinized and rehydrated through a graded series
of ethanol, then subjected to digestion with proteinase
K (Zymed) for 10 min at 37 ◦C. After washing, Image-
iT FX signal enhancer (Molecular Probes, Eugene, OR,
USA) was applied for 30 min at room temperature. The
sections were again washed and then non-specific binding
sites were blocked by incubating with 5% normal chicken
serum for 30 min at 37 ◦C. After a single wash in PBS,
sections were incubated with anti-CAR (Upstate Cell
Signaling Solutions, Lake Placid, NY, USA) or MOPC
21 isotype control (both at 5 µg/ml in 1% chicken
serum in PBS) for 1 h at 37 ◦C. After washing in PBS,
AlexaFluor 488-labeled chicken anti-mouse IgG (1 : 100;
Molecular Probes) was applied and incubated for 30 min
at room temperature. After washing in PBS, coverslips
were applied using ProLong Gold anti-fade mounting
medium (Molecular Probes).
For the ‘fence’ system, ‘fences’ were placed on top
of collagen-coated glass coverslips (Becton Dickinson)
placed in 6-well culture plates. Caco-2 cell culture was
done as described above for the ‘fence’ system. Cells were
washed with PBS and fixed with 3% paraformaldehyde
prior to immunofluorescence staining. In some cases,
cells were permeabilized by applying 0.2% Triton X-100
for 15 min. Cells were rinsed with PBS, then blocked
with 10% goat serum in PBS for 20 min. Primary
antibody was applied (anti-CAR, ascites fluid 1 : 50) for
1–3 h at room temperature. Cells were washed twice
with PBS, then fluorescein isothiocyanate (FITC) or
AlexaFluor 488 conjugated donkey or goat anti-mouse
IgG secondary antibody in 10% goat serum was applied
(1 : 100 dilution). Cells were incubated in the dark for 1 h
at room temperature. Cells were rinsed twice with PBS,
and the coverslips were mounted on glass slides using
ProLong mounting medium. Cells were imaged with a
Leitz Aristoplan light microscope fitted with a fluorescence
filter and equipped with a Diagnostics Spot-RT cooled
CCD digital camera.
Data analysis
Statistical significance was determined using Student’s t
test. p values less than 0.05 were considered statistically
significant. Data are shown as mean ± standard error of
the mean (SEM).
Results
Adenoviral transduction of intestinal
explants
We observed the presence of shortened enterocytes at
the edges of several explants (Figure 1) occasionally
also extending as a monolayer along the bottom of
the tissue. The epithelial lineage of the cuboidal cells
observed along the bottoms of some explants was
confirmed by immunofluorescent staining for cytokeratin
(Figure 1d). These shortened epithelial cells at the tissue
edges were noted to be transduced more frequently by
Ad5CMV-betaGal than were normal columnar enterocytes
(Figures 1a–1c).
Columnar epithelial cells were present in all five
sections examined from each explant (total 7 subjects,
17 explants, 85 sections); transduction of columnar
epithelial cells was observed in four sections (5% of
the 85 total occurrences of columnar epithelial cells),
representing 3 of the 17 explants and 2 of the 7 subjects.
Attenuated (cuboidal to squamoid) epithelial cells were
present at explant edges in at least one explant from
each of the seven subjects (12 of 17 total explants;
54 of the 85 total sections examined); transduction of
attenuated cells at explant edges was observed in at
least one section from five of the seven subjects [total
of 14 (26%) of the 54 occurrences; total of 6 of the
12 explants in which the morphology was observed].
These attenuated epithelial cells were noted to extend as
monolayers beneath at least one explant from five of the
seven subjects (8 of 17 total explants; 31 of the 85 total
sections examined); transduction of these monolayer cells
was observed in explants from three of the five subjects
in which monolayer formation was observed [total of 8
(26%) of the 31 occurrences; total of 3 of the 8 explants
in which such a monolayer was observed].
Adenoviral transduction in the
wounded monolayer system
We compared the transduction efficiency of Ad5CMV-
betaGal in repairing (wounded) and non-repairing (non-
wounded) Caco-2 cell monolayers. Transduction in the
confluent non-wounded monolayers, and in the confluent
areas of the wounded monolayers, was low, consistent
with prior studies [4,5]. Migrating (repairing) cells in
the wounded monolayers expressed much higher levels
of the LacZ reporter gene compared to confluent cultures
(Figure 2a). Transduction increased with time and dose
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Figure 1. Endoscopic biopsies from the second portion of the
duodenum were obtained from patients undergoing esopha-
gogastroduodenoscopy for clinical indications with endoscopi-
cally normal mucosa. The biopsies were kept in explant culture
for 27–28 h and exposed to Ad5CMV-betaGal (applied apically
at the start of culturing) throughout the culture period. The
explants were then fixed and stained en bloc with X-Gal. Sections
of the fixed tissue were counterstained with Nuclear Fast Red.
X-Gal-stained, i.e. transduced, nuclei appear black. (a) Epithelial
cells at the edge of the tissue are shortened and extend as a
monolayer across a portion of the bottom of the explant; ×10.
A single transduced nucleus (arrow) is seen within this mono-
layer. Inset is ×100 of the bracketed region. (b) Transduced
nuclei (arrows) are present among the shortened epithelial cells
at each end of the explant; ×10. The lower images are ×100 of
the left and right ends of the explant and a representative region
of columnar epithelium at the center of the explant. (c) Villus
on the left has columnar epithelial cells (×10; inset is ×100 of
the epithelium). Villus on the right has cuboidal to squamoid
epithelium; transduced cells are present (less intensely stained
cells indicated by arrows). Image to the right is ×100 of the
bracketed region. (d) The epithelial lineage of the cuboidal to
squamoid cells observed along the bottoms of some explants
was confirmed by immunofluorescent staining of a 48 h cul-
tured explant for cytokeratin. Upper panel, ×10 anti-cytokeratin
(upper inset is ×40 of columnar epithelial cells; lower inset is
×40 of cuboidal cells in the monolayer along the bottom of the
explant). Lower panel, ×10 MOPC isotype control
of the adenoviral vector, with virtually 100% of cells
along the migrating edge being transduced after 48 h
incubation at MOI of 1000 (Figure 2a). These differences
were quantified using bioluminescence imaging after
Ad5CMV-luc incubation. As seen in Figure 2b, at the
MOI of 1000 there were significantly increased photon
counts for wounded monolayers compared to non-
wounded monolayers (60.97 ± 3.41 vs. 40.04 ± 6.05 fold
untransduced control, p < 0.05).
Adenoviral transduction in the ‘fence’
system
X-Gal staining after Ad5CMV-betaGal transduction
showed a similar transduction pattern to that seen in
the wounded monolayer system. When monolayers were
transduced in their confluent, non-migrating state (‘fence’
on) there were few transduced cells scattered throughout
the culture with only a rare transduced cell observed at
the culture edge (Figure 3a, bottom row). When mono-
layers were transduced in their migrating state (after
‘fence’ removal) we saw a much higher number of stained
cells (Figure 3a, top row). Transduced cells were local-
ized mainly on the migrating edge of the culture. There
was increased transduction at 48 h compared to 24 h
(Figure 3a) with virtually 100% transduction of cells
along the leading edge after 48 h at MOI 1000 (shown at
lower magnification, Figure 3b).
Transduction efficiency was quantified using biolumi-
nescence imaging after Ad5CMV-luc infection. There was
a time- (24 vs. 48 h) and dose-dependent (MOIs of 0,
100, 1000) increase in transduction efficiency (Figures 4a
and 4b) for both the non-migrating and migrating state
of the monolayer. At corresponding MOIs, the biolumi-
nescent activity observed was much higher in expand-
ing monolayers. Furthermore, photon emission patterns
resembled the pattern that was seen with X-Gal staining,
in that light emission was higher around the perimeter of
the culture (Figure 4c). The effect was again more pro-
nounced at the high MOI of 1000 (Figure 4c, bottom left
well). The effect of cell proliferation on transducibil-
ity was studied at the intermediate MOI of 200. As
shown in Figure 4d, mitomycin C pre-treatment to arrest
cell proliferation in expanding monolayers did not affect
transduction efficiency. The difference between expand-
ing and non-expanding monolayers was consistent with
the previous experiments.
Apical vs. basolateral adenoviral
transduction in Caco-2 monolayers
We compared differences in transduction by Ad5CMV-
luc(loxP) after apical vs. basolateral application to Caco-2
monolayers grown on collagen-coated culture inserts.
At all MOIs tested apical transduction, while limited,
was 4–7-fold higher than basolateral (Figure 5a). Similar
results were obtained with cells grown on uncoated inserts
(not shown).
When cells were transduced apically at a MOI of
200 with the Ad5CMV-luc(loxP), EGTA pre-treatment
resulted in a 70% increase in bioluminescence activity
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Figure 2. Transduction of wounded vs. non-wounded Caco-2 monolayers. (a) X-Gal staining. Wounded Caco-2 monolayers were
exposed to Ad5CMV-betaGal 48 h after wounding at a MOI of 1000. After 2 h, additional maintenance medium was added and
infection was allowed to occur for up to 48 h. Parallel non-wounded monolayers were likewise transduced. Transduction was
assayed by X-Gal staining. (b) Bioluminescence activity. Data are mean ± SEM of photon counts (as fold untransduced control) of
wounded (solid bars) and non-wounded (open bars) monolayers after 48 h of total incubation time with Ad5CMV-luc; ∗p < 0.05,
between wounded and non-wounded monolayers at same MOI; n = 4
Figure 3. (a) X-Gal staining of expanding (‘fence’ off, upper row) and non-expanding (‘fence’ on, lower row) monolayers utilizing
the ‘fence’ system. Caco-2 monolayers were exposed to Ad5CMV-betaGal at a MOI of 1000 for 2 h at 37 ◦C. Additional maintenance
medium was added to the cells and infection was allowed to occur for 24 or 48 h. Cells on the edge of expanding monolayers
stained blue. (b) X-Gal staining of expanding (‘fence’ off) monolayers as seen at lower magnification. Two different magnifications
are shown. Virtually 100% of cells on the migrating edge stained blue
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Figure 4. (a, b) Bioluminescence activity in non-expanding (‘fence’ on, open bars) and expanding (‘fence’ off, solid bars) monolayers
transduced with Ad5CMV-luc vectors utilizing the ‘fence’ system. Caco-2 monolayers were exposed to Ad5CMV-luc for 2 h at 37 ◦C.
Additional maintenance medium was added to the cells and infection was allowed to occur for 24 (a) or 48 h (b). Data
are mean ± SEM of photon counts (as fold untransduced control); n = 4–5; ∗p < 0.05 between expanding and non-expanding
monolayers at the same MOI. (c) Bioluminescence imaging of expanding (‘fence’ off) Caco-2 monolayers utilizing the ‘fence’
system. (d) Effect of mitomycin C pre-treatment on transduction efficiency of expanding monolayers. Confluent monolayers were
pre-treated with 20 µg/ml mitomycin C for 2 h [17] and then allowed to expand for 24 h. Cells were transduced with a 1 : 1
mixture of Ad5CMV-luc(loxP)/Ad5CMV-betaGal at MOI of 200. After 2 h additional maintenance medium was added to the cells and
infection was allowed to occur for 48 h. No significant difference was observed between monolayers pre-treated with mitomycin
C and untreated monolayers. Data are mean ± SEM of photon counts, n = 4; ∗p < 0.05, between expanding and non-expanding
monolayers
(204 ± 8.63 vs. 120.3 ± 5.53, mean of photon counts
fold untransduced control ± SEM of 3 replicates, p <
0.01) (Figure 5b). Transduction by the non-CAR-binding
Ad5SHORT vector was much less efficient, and no increase
was observed with EGTA pre-treatment.
Transduction inhibition experiments
When expanding Caco-2 cell monolayers were pre-
incubated with an anti-CAR antibody (RmcB; 1 : 50
dilution of ascites fluid) and subsequently transduced
with Ad5CMV-luc(loxP)/Ad5CMV-betaGal at MOI 200,
we observed a 36.5% decrease in transduction effi-
ciency (Figure 6a). Pre-incubation with a 0.4 mM solu-
tion of the RGD peptide resulted in an 18.3% reduc-
tion in transduction efficiency (Figure 6a). Pre-incubation
with anti-CAR antibody (1 : 50 dilution of ascites fluid),
followed by transduction at the high MOI of 1000,
resulted in 39.4% reduction in transduction efficiency
(Figure 6b). However, pre-incubation with the 0.4 mM
RGD peptide did not affect adenoviral transduction
at this MOI; a significant reduction in transduction
(45.4%) was seen when the concentration of the RGD
peptide was increased to 1 mM (Figure 6b). Identi-
cal blocking experiments were performed using non-
expanding monolayers which represent fully differenti-
ated Caco-2 cells. At the MOI of 200, pre-incubation
with 1 : 50 RmcB ascites fluid reduced transduction lev-
els by 32.2% (Figure 6c). We noted no inhibition of
transduction by the low concentration (0.4 mM) of the
RGD peptide. These results were confirmed in exper-
iments with differentiated Caco-2 monolayers grown
on collagen-coated cell culture inserts, where RmcB
pre-incubation resulted in a similar degree of transduc-
tion inhibition while the RGD peptide had a negligi-
ble effect (data not shown). However, when the MOI
was increased to 1000, neither pre-incubation with the
anti-CAR monoclonal antibody or the high concentra-
tion of the RGD peptide managed to block transduction
(Figure 6d).
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Figure 5. Difference in apical and basolateral adenoviral
transduction of differentiated Caco-2 cells after (a) direct
application of the virus to the apical or basolateral surface and
(b) apical application of the virus after disruption of the tight
junctions with EGTA pre-treatment. Caco-2 cells were grown
in Transwell inserts and allowed to form a fully differentiated
monolayer. Medium was aspirated and new medium containing
the Ad5CMV-luc(loxP) vector at the desired MOI was added
on the apical or basolateral side of the monolayer. Basolateral
transduction was carried out by inverting the inserts. To disrupt
the tight junctions, 2.5 mM EGTA in DMEM was added to both
the apical and basolateral chambers for 45 min at 37 ◦C prior
to virus application. Adenovirus transduction (MOI 200) was
allowed to proceed for 2 h at 37 ◦C at which point medium
was aspirated, replenished with fresh medium, and cells were
returned to the incubator. Luminescence activity was assayed
after 48 h and is expressed as: (a) mean ± SEM of photon
counts (as fold untransduced control), ∗p < 0.05, between
apical and basolateral transduction at the same MOI, n = 3
and (b) mean ± SEM of photon counts (as fold background
luminescence), ∗p < 0.05, between pretreated and unpretreated
cultures, n = 3
Transduction studies with Ad5/Ad41
chimeric vectors expressing the short
fiber protein
When non-CAR-binding Ad5SHORT vectors were applied
to systems of wounded/migrating Caco-2 cells we
noticed a dramatic decrease in transduction efficiency
as compared to standard Ad5 vectors. Quantified as
bioluminescent activity and shown in Figure 7 for the
‘fence’ system, at the three MOIs tested (10, 100, 1000)
the chimeric vector resulted in 3.5-, 16.5- and 8.8-
fold fewer photon counts (fold untransduced control),
respectively. The reduced transduction efficiency of these
vectors was also confirmed with X-Gal staining, which
showed a dramatic decrease in transduced migrating
(repairing) cells (data not shown).
Immunofluorescence studies
CAR staining was observed in the apical membrane
of enterocytes in the intestinal explants (Figure 8a).
No difference in intensity or localization of CAR
immunofluorescent staining was appreciated between
columnar enterocytes and attenuated epithelial cells.
MOPC isotype controls were negative.
In the Caco-2 cell ‘fence’ system (Figure 8b),
immunofluorescent staining for CAR in non-permeabilized
expanding monolayers (‘fence’ off, upper panel) was
observed in areas of the migrating edge, with lim-
ited staining in confluent regions of the cultures. Non-
permeabilized non-expanding monolayers (‘fence’ on, not
shown) showed limited staining throughout. In perme-
abilized expanding monolayers (‘fence’ off, middle and
lower panels) staining was observed in confluent as well
as migrating cells. While confluent areas of the culture
showed prominent membrane staining (lower portion of
middle panel), staining of cells in the migrating edge
(lower panel and upper region of middle panel) appeared
to be largely cytoplasmic or perinuclear, with fine mem-
brane staining also present. An intervening region of
poorly stained cells was also observed (center portion
of middle panel). In contrast, permeabilized confluent
monolayers (‘fence’ on, not shown) showed prominent
membrane staining throughout. Omission of primary anti-
body or staining with a MOPC isotype control resulted in
weak background levels of fluorescence.
Discussion
A major obstacle to successful implementation of
adenoviral vectors in gastrointestinal gene delivery is the
low transducibility of mature intestinal epithelial cells.
This study, utilizing human endoscopic small intestinal
biopsies and in vitro models of intestinal wound healing,
demonstrates that wounded intestinal epithelial cells are
much more susceptible to transduction by commonly used
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Figure 6. Transduction inhibition in (a) expanding (‘fence’ off) monolayers at MOI of 200, (b) expanding (‘fence’ off) monolayers at
a MOI of 1000, (c) non-expanding (‘fence’ on) monolayers at a MOI of 200, and (d) non-expanding (‘fence’ on) monolayers at MOI
of 1000. Caco-2 cell monolayers grown using the ‘fence’ system were pre-incubated for 2 h at room temperature with the following
blocking solutions: 1 : 50 dilution of RmcB ascites fluid, GRGDSP 0.4 mM and GRGDSP 1 mM. Subsequently, cells were transduced
with either Ad5CMV-luc(loxP) or Ad5CMV-luc(loxP)/Ad5CMV-betaGal for 2 h at 37 ◦C. Luminescence activity was assayed after 48 h
and is expressed as mean ± standard deviation (SD) of photon counts (as % unpretreated control); the error bar for the control
represents SD of photon count measurements. ∗p < 0.05, compared to non-blocked monolayers; n = 4–6
Figure 7. Differences in transduction efficiency of nor-
mal and modified Ad5 vectors applied to expanding
Caco-2 monolayers utilizing the ‘fence’ system. Expanding
(‘fence’ off) Caco-2 monolayers were exposed to 1 : 1 mix-
tures of Ad5CMV-luc(loxP)/Ad5CMV-betaGal or Ad5SHORT-luc/
Ad5SHORT-betaGal for 2 h at 37 ◦C. Additional maintenance
medium was added to the cells and infection was allowed to
occur for 48 h. Data are mean ± SEM of photon counts (as fold
untransduced control) after Ad5 (open bars) and Ad5SHORT
(solid bars) administration, ∗p < 0.01, between the two vectors
at the same MOI; n = 4–5
adenoviral vectors and might represent a valid target for
the delivery of therapeutic genes to the intestine. The
striking increase in transducibility occurs at the leading
edge of epithelial cell migration and does not appear
to be related to cell proliferation. We demonstrated a
significant role of CAR in the increased transducibility of
these migrating cells. For these cells, CAR appears to have
increased accessibility even to apically applied adenoviral
vectors, an observation contrary to previously published
reports on other epithelial cell types [11,23].
Mature, differentiated enterocytes appear to be resis-
tant to transduction by commonly used adenoviral vectors
[5,6]. The same low levels of transduction have been
reported for other epithelial cell types such as airway
epithelial cells [11,24–26]. Studies utilizing Caco-2 cells
suggest that the decrease in integrin expression as cells dif-
ferentiate is responsible for the low transduction efficiency
[4,5]. For airway epithelium, the low transducibility has
been attributed to the absence of CAR on the apical cell
membrane [11,25]. Furthermore, it was recently demon-
strated that CAR acts as an adhesion molecule mediating
homotypic cell-cell contacts, being localized in the api-
cal junction complex helping maintain epithelial integrity
[23,27]. To our knowledge CAR expression has not been
studied in intestinal epithelial cells.
Although it is clear that healthy intestinal epithelium
offers a poor target for adenoviral vectors, this might not
be the case with inflamed or wounded intestinal tissue.
Restituting or healing intestinal epithelium occurs in a
variety of clinical settings from foreign body or caustic
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Figure 8. CAR immunofluorescence. (a) Intestinal biopsies. Villus stained with anti-CAR (upper panel, ×40); MOPC isotype control
(second panel, ×40). Enterocyte staining: columnar cells (third panel, ×100); cuboidal cells (fourth panel, ×100). (b) Caco-2 cell
expanding monolayer (‘fence’ off) in the ‘fence’ system. Non-permeabilized monolayer (upper panel, ×20); arrows indicate areas
of increased staining along the migrating edge. Permeabilized monolayer (middle panel, ×20; lower panel, ×40)
ingestion, to viral gastroenteritis, to chronic inflammation
associated with Crohn’s disease. Evidence for increased
transducibility of damaged intestinal epithelium exists
as intrarectal Ad5 administration resulted in higher
transgene expression levels in mice with colitis compared
with normal mice [28].
Utilizing an organ culture model, we studied transduc-
tion of intestinal epithelium of human endoscopic small
intestinal biopsies. Human intestinal explants [29] have
been used for a variety of investigations including the
effect of insulin on epithelial cell proliferation [30] and
the synthesis of brush border membrane proteins [31].
We noted that shortened epithelial cells at the edges of
explants had a higher rate of transduction by Ad5CMV-
betaGal than did epithelial cells that had maintained a
columnar morphology (Figure 1). In addition, epithelial
cells in damaged areas of epithelium from patients with
inflammatory bowel disease are transduced more readily
than intact epithelium [16]. The monolayer formation
along the lower surface of explants by less differentiated
migrating cells is likely analogous to ‘outgrowths’ of sim-
ilar poorly differentiated epithelial cells from explants of
intestine, nasal polyp, and other tissues when the explants
are cultured directly on collagen-coated dishes [32,33].
Explant outgrowths have been considered to be a model
of epithelial regeneration [33]. These data suggest that
intestinal epithelial cells with a de-differentiated phe-
notype, similar to that observed in restituting intestinal
epithelium, might represent a better target for adenoviral
vectors.
Several models in the literature use migrating or
subconfluent Caco-2 cells to model wound healing
[34–39]. The migration characteristics of the Caco-2
cells in these models resemble those seen in vivo [10].
Migrating through the wound as a sheet, they exhibit a
less differentiated phenotype with squamous morphology,
downregulation of brush border enzymes and integrin,
and cytoskeleton reorganization that facilitates cell
motility [10]. Two processes are involved in the expansion
of the monolayers: cell migration and cell proliferation
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[18,19]. To better study the mechanism of the increased
transduction of de-differentiated enterocytes we noted in
the explant, we utilized two in vitro models of mucosal
wound healing: the wounded monolayer and the ‘fence’-
migration model.
Intestinal epithelial cells are transduced by adenovi-
ral vectors in a dose- and time-dependent manner [5,6].
This dose dependence was observed for both confluent
and expanding monolayers. The most striking differences
in transduction efficiency were observed between con-
fluent and expanding monolayers. Expanding monolayers
showed up to 3-fold higher transducibility (Figure 4) with
the majority of the transduced cells present in the migrat-
ing edge in both systems (Figures 2 and 3). Since the
migrating cells represent only a small percentage of the
total number of cells present in the culture, the observed
differences constitute a substantial increase in transgene
expression. In fact, at the high MOI of 1000, transduc-
tion efficiency of these migrating cells was almost 100%
(Figures 2 and 3). This is in sharp contrast to the low
transducibility observed for confluent differentiated Caco-
2 cells both in these studies and in the literature. The
high transducibility of this subset of Caco-2 cells suggests
that wounded intestinal epithelial cells represent a target
that may allow sufficient expression of therapeutic genes
delivered by adenoviral vectors.
Seidman et al. reported variations in adenoviral
transducibility of lung carcinoma A549 cells during
the cell cycle that were associated with changes in
the expression of the virus receptor. Virus application
during the M phase of the cell cycle resulted in higher
transducibility [40]. In the ‘fence’ system, pre-treatment
of expanding monolayers with mitomycin C, an inhibitor
of cell proliferation, did not affect the transducibility
of the migrating cells (Figure 4d), suggesting that the
mechanism that accounts for their higher transducibility
is related to changes that occur during the migration
process rather than increased viral gene expression due
to the proliferating stage of the cells. CAR and integrins
are believed to be the two most important receptors
that facilitate adenovirus entry into cells. In the case of
Caco-2 cells, a clear role of integrins in the transduction
process has been documented [4] and was confirmed in
our study. In our study, transduction of non-expanding
monolayers was not affected by integrin blocking with the
RGD peptide (Figures 6c and 6d). This is not unexpected
given the low level of integrin expression in confluent
monolayers [4,5]. The differences between these data and
the slight reduction reported in the literature are probably
due to different experimental protocols. We saw a clear
inhibition of transduction in expanding monolayers pre-
incubated with the RGD peptide (Figures 6a and 6b). As
cells migrate, cytoskeleton reorganization takes place and
integrins are redistributed to the migrating cell surface
[10,41], thereby making them accessible to the applied
adenoviral vectors. It is worth noting that we had to
increase RGD peptide concentration from 0.4 mM to
1 mM to achieve inhibition at the high MOI. It is likely
that, as almost 100% of cells on the migrating edge
get transduced with the increased viral load, a higher
concentration of RGD peptide is required to observe
significant blocking.
To our knowledge, our data is the first to support
a role for CAR in mediating transduction of intestinal
epithelial cells. CAR blocking with a monoclonal anti-CAR
antibody resulted in reduction of transduction efficiency
in expanding monolayers (Figures 6a and 6b). The level
of blocking observed at the MOI of 200 was similar to
that observed for non-expanding monolayers. However,
at the MOI of 1000, while CAR blocking did not affect
non-expanding monolayers, expanding monolayers were
affected to the same extent as at the MOI of 200. We
hypothesize that the reduced transduction after anti-
CAR mAb preincubation is due to increased interactions
between CAR on the surface of the migrating cells and the
applied viruses. The fact that we see significant inhibition
of transduction of non-expanding monolayers is a little
surprising since CAR has been suggested to be localized
either basally or at the tight junction complex towards the
apical pole of the lateral membrane [27,42,43]. Previous
studies have shown that airway epithelia [11] show
higher transduction efficiency from the basolateral side.
Our transduction inhibition data suggest that, in Caco-2
cells, CAR is accessible to adenovirus even after apical
application of the virus (Figure 6). Furthermore, our
studies comparing apical to basolateral transduction of
differentiated Caco-2 cells showed an opposite pattern to
other epithelial cell lines, with significantly higher apical
transduction (Figure 5). Higher apical transduction of
Caco-2 cells has been previously reported [6]. Disruption
of the tight junctions led to a modest increase (less than 2-
fold) in transduction efficiency (Figure 5), consistent with
the observation in Caco-2 cells that apical interactions
between the cell surface and receptors are favored over
basolateral ones. Similar treatment in airway epithelium
has been reported to lead to an 8–9-fold increase in
transduction efficiency [11], suggesting that, in airway
epithelium, the virus selectively binds to receptors on
the basolateral surface. To our knowledge, this is the
first study to demonstrate that in an epithelial cell line,
CAR is accessible from the apical surface. Although the
overall transduction is still limited, this finding supports
the concept of lumenal delivery of adenovirus to the
intestine via the oral route.
The results obtained with the chimeric Ad5/Ad41
vector further support a higher accessibility of CAR in cells
on the migrating edge of expanding Caco-2 cultures. Ad41
is a subgroup F enterotropic adenovirus with significant
structural differences compared to Ad5. The most notable
of these is that Ad41 particles carry two fibers of different
lengths and different primary sequences, designated the
long and short fiber [44]. The short fiber has been
shown to be unable to bind to CAR or block adenoviral
transduction in culture [45]. As a result, Ad5SHORT
vectors that carry the short fiber of Ad41 on their capsid
are unable to initiate transduction by binding to CAR. We
observed a dramatic decrease in transduction efficiency of
the chimeric vectors compared to the parent Ad5 vector
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in both confluent (Figure 5) and expanding (Figure 7)
Caco-2 monolayers. In the latter, the majority of Ad5
transduction occurs in the migrating cells at the edge of
the culture. As the chimeric vectors do not bind CAR,
the overall level of transgene expression in expanding
monolayers transduced with these vectors is significantly
lower than that observed with Ad5.
Immunofluorescence studies demonstrated increased
CAR immunoreactivity in the cells at the migrating edge
of non-permeabilized Caco-2 monolayers as compared to
areas of confluence (Figure 8b). The role of CAR in the
increased transduction of the migrating cells could be
due to either increased CAR expression or redistribution
of existing CAR receptors on the cell surface. Permeabi-
lized monolayers showed increased staining intensity and
a somewhat different pattern of staining, with promi-
nent membrane staining in confluent areas and increased
cytoplasmic/perinuclear staining in migrating cells, which
also retained fine membrane staining. Because membrane
staining of differentiated Caco-2 cells by anti-CAR was
not well seen unless the monolayers were permeabi-
lized, the epitope of the transmembrane CAR protein
that is recognized by the antibody appears to reside
predominantly intracellularly or in the transmembrane
domain in differentiated Caco-2 cells. The observation
of prominent staining of migrating cells at the edges
of non-permeabilized monolayers suggests a reorienta-
tion plus/minus redistribution of CAR protein in this cell
population. The intracellular staining of permeabilized
migrating cells suggests that there may also be increased
CAR synthesis. Although there are no available data on
Caco-2 cells, differentiated and undifferentiated airway
epithelial cells have been shown to express similar levels
of CAR mRNA [11]. It has been reported that, during
epithelial migration, there are changes in the cellular dis-
tribution of cytoskeleton proteins and adhesion molecules,
such as integrins [10,41]. Since CAR is a cell-cell adhesion
molecule normally present at the tight junction complex,
it might also be undergoing cellular redistribution thus
being more accessible to viral vectors on the cell surface
of the restituting cells during intestinal wound healing. A
role of CAR in the migration/restitution process has been
suggested in other organs including the nervous system
[46], the heart [47], and the carotid artery [48].
Immunofluorescence studies in explant cultures
demonstrated CAR immunoreactivity in the apical mem-
branes of both columnar and cuboidal enterocytes. We
were unable to demonstrate a difference in intensity or
localization of CAR immunofluorescent staining between
the columnar and attenuated epithelial cells. However,
this may reflect the limitations of quantitation by this
technique and the fact that the tissue was in effect ‘perme-
abilized’ by sectioning as well as by xylene deparaffiniza-
tion. The lack of cytoplasmic or perinuclear CAR staining
in the attenuated epithelial cells may reflect the difficulty
in the explant model of capturing epithelial cells which
are truly of the migrating (leading edge) phenotype.
In summary, using human intestinal biopsy cultures
and in vitro models of intestinal epithelial wound healing
we have demonstrated that migrating intestinal epithelial
cells with a de-differentiated phenotype are transduced
much more efficiently than normal, fully differentiated
cells. The effect appears to be related to integrin and
CAR expression by the migrating cells that is associated
with the migration process and is not coupled with the
proliferative state of the cells. Our data is consistent with
greater accessibility of CAR on the cell surface rather than
increased access of the virus to the basolateral surfaces of
the cells. The involvement of integrins in transduction of
migrating epithelial cells is consistent with literature data
that show reorganization of the cytoskeleton and inte-
grin redistribution during the migration process of Caco-2
cells. The novel finding here is the significant role of CAR
in mediating the increased transducibility of migrating
cells possibly related to receptor redistribution occurring
during migration. The flattened intestinal epithelial cells
of the explants and the migrating Caco-2 cells in the
in vitro models used in this study are similar to restituting
intestinal epithelial cells seen in vivo in inflamed or dam-
aged tissue. As a result, these cells might represent a ther-
apeutic target for adenoviral vectors in intestinal diseases
where healing of damaged tissue occurs, such as radiation-
induced intestinal injury or inflammatory bowel disease.
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